Skip to content
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Sign in
Subscribe
Clinical Topics
View All
Addiction
ADHD
Alzheimer’s Disease
Anxiety
Bipolar Disorder
Depression
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Evolving Psychedelic Paradigm
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
JCP Podcast
Rounds in the General Hospital
View All
Emmanuel Stip, MD, MSc
JCP
Letter to the Editor
Cost Reductions Associated With Long-Acting Injectable Antipsychotics According to Patient Age
October 25, 2017
Emmanuel Stip
JCP
Letter to the Editor
Physician Characteristics Associated With Prescription of Long-Acting Injectable Antipsychotics
October 25, 2017
Emmanuel Stip
JCP
Original Research
A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Tolerability of High-Dose Quetiapine in Patients With Persistent Symptoms of Schizophrenia or Schizoaffective Disorder
June 14, 2011
Hans Eriksson
,
Emmanuel Stip
,
Alain Labelle
, et al
JCP
Original Research
Selective Serotonin Reuptake Inhibitor (SSRI) Add-On Therapy for the Negative Symptoms of Schizophrenia: A Meta-Analysis
April 16, 2007
Emmanuel Stip
,
Stéphane Potvin
,
Amir Ali Sepehry
, et al
JCP
Original Research
Neural Correlates of the Affect Regulation Model in Schizophrenia Patients With Substance Use History: A Functional Magnetic Resonance Imaging Study
March 15, 2006
Emmanuel Stip
,
Adham Mancini-Marïe
,
Stéphane Potvin
, et al
JCP
Letter to the Editor
Need for a New Framework to Understand the Mechanism of All Antipsychotics
October 31, 2000
Emmanuel Stip
,
Peter F. Liddle
,
Jean Paul Soucy
